ESC Premium Access

Cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: a systematic review and meta-analysis

Congress Session

About the speaker

Professor Michel Burnier

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)
14 presentations
0 follower

5 more presentations in this session

New features of use of moxonidine as telomerase activator

Speaker: Doctor E. Dudinskaya (Moscow, RU)

Thumbnail

Renal artery branch denervation: evaluation of lesion characteristics using a thermochromic liquid crystal phantom model

Speaker: Associate Professor P. Kovoor (Sydney, AU)

Thumbnail

Regulation of cardiac ADAM-10 activity by sympathoadrenergic modulation and the role for RAGE-sRAGE balance and myocardial remodeling

Speaker: Mrs O. Zamyatkin (Saarbruecken, DE)

Thumbnail

Calcium channel blocker monotherapy versus combination with renin-angiotensin system blockers in the development of new-onset diabetes mellitus in hypertensive Korean patients

Speaker: Professor A. Her (Chuncheon, KR)

Thumbnail

Difference in renal parenchymal perfusion after renal denervation comparing treated vs. non-treated arteries

Speaker: Mr R. Schmieder (Munich, DE)

Thumbnail

Access the full session

Hypertension treatment

Speakers: Professor M. Burnier, Doctor E. Dudinskaya, Associate Professor P. Kovoor, Mrs O. Zamyatkin, Professor A. Her...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk